Oriola
Finnish medical industry business
OKDAV Nasdaq Helsinki
LEI 549300UWB1AIR85BM957
Follow Oriola
Weekly email: filings, results
Revenue, last year
€1.9B
+13.5% vs prior year
Net income
−€27.2M
−35.3% vs prior year
EPS, diluted
−€0.15
−36.4% vs prior year
Operating cash flow
€60M
+55% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | €1.9B | −€27.2M |
| FY24 | €1.7B | −€20.1M |
| FY23 | €1.5B | −€20.7M |
| FY22 | €1.5B | −€2.4M |
| FY21 | €1.9B | €11.3M |
| FY20 | €1.8B | €11.3M |
| FY19 | €1.7B | €8M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 0.1% | −1.4% |
| FY24 | 0.8% | −1.2% |
| FY23 | −0.4% | −1.4% |
| FY22 | 0.5% | −0.2% |
| FY21 | 1.1% | 0.6% |
| FY20 | 1.1% | 0.6% |
| FY19 | 0.9% | 0.5% |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | €12.7M | €100K |
| FY24 | €12.7M | €100K |
| FY23 | €10.9M | €100K |
| FY22 | €7.3M | €100K |
| FY21 | €5.4M | €100K |
| FY20 | €16.3M | €100K |
| FY19 | €16.3M | €100K |
- Oriola
- Healthcare median
Show the numbers
| Year | Oriola | Healthcare median |
|---|---|---|
| FY25 | −1.4% | −30.6% |
| FY24 | −1.2% | −47% |
| FY23 | −1.4% | −58% |
| FY22 | −0.2% | −80.4% |
| FY21 | 0.6% | −71.9% |
| FY20 | 0.6% | −62.2% |
| FY19 | 0.5% | −46.3% |